Literature DB >> 18584870

II. Correlations between secondary structure stability and mutation frequency during somatic hypermutation.

Barbara E Wright1, Karen H Schmidt, Nick Davis, Aaron T Hunt, Michael F Minnick.   

Abstract

The role of secondary structures and base mutability at different levels of transcription and supercoiling is analyzed in variable region antibody genes VH5, VH94 and VH186.2. The data are consistent with a model of somatic hypermutation in which increasing levels of transcription and secondary structure stability correlate with the initial formation of successive mutable sites. Encoded differences exist in stem length and the number of GC pairs at low versus high levels of transcription in CDRs. These circumstances simplify the complexities of coordinating mutagenesis by confining this process to each mutable site successively, as they form in response to increasing levels of transcription during affinity maturation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18584870      PMCID: PMC2529022          DOI: 10.1016/j.molimm.2008.05.012

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  12 in total

1.  The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially.

Authors:  C Rada; C Milstein
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

2.  Predicting mutation frequencies in stem-loop structures of derepressed genes: implications for evolution.

Authors:  Barbara E Wright; Dennis K Reschke; Karen H Schmidt; Jacqueline M Reimers; William Knight
Journal:  Mol Microbiol       Date:  2003-04       Impact factor: 3.501

3.  Mechanisms by which transcription can regulate somatic hypermutation.

Authors:  B E Wright; K H Schmidt; M F Minnick
Journal:  Genes Immun       Date:  2004-05       Impact factor: 2.676

4.  Spontaneous mutation in the Escherichia coli lacI gene.

Authors:  R M Schaaper; R L Dunn
Journal:  Genetics       Date:  1991-10       Impact factor: 4.562

Review 5.  Mutation drift and repertoire shift in the maturation of the immune response.

Authors:  C Berek; C Milstein
Journal:  Immunol Rev       Date:  1987-04       Impact factor: 12.988

6.  Hypermutable bases in the p53 cancer gene are at vulnerable positions in DNA secondary structures.

Authors:  Barbara E Wright; Jacqueline M Reimers; Karen H Schmidt; Dennis K Reschke
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

7.  Increased transcription rates correlate with increased reversion rates in leuB and argH Escherichia coli auxotrophs.

Authors:  Jacqueline M Reimers; Karen H Schmidt; Angelika Longacre; Dennis K Reschke; Barbara E Wright
Journal:  Microbiology       Date:  2004-05       Impact factor: 2.777

8.  Mechanisms of genotoxin-induced transcription and hypermutation in p53.

Authors:  Barbara Wright; Jacqueline Reimers; Karen Schmidt; Evan Burkala; Nick Davis; Ping Wei
Journal:  Cancer Cell Int       Date:  2006-12-01       Impact factor: 5.722

9.  Intricate targeting of immunoglobulin somatic hypermutation maximizes the efficiency of affinity maturation.

Authors:  Nai-Ying Zheng; Kenneth Wilson; Matthew Jared; Patrick C Wilson
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

10.  Detection of chromatin-associated single-stranded DNA in regions targeted for somatic hypermutation.

Authors:  Diana Ronai; Maria D Iglesias-Ussel; Manxia Fan; Ziqiang Li; Alberto Martin; Matthew D Scharff
Journal:  J Exp Med       Date:  2007-01-16       Impact factor: 14.307

View more
  11 in total

Review 1.  Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases.

Authors:  Sachini U Siriwardena; Kang Chen; Ashok S Bhagwat
Journal:  Chem Rev       Date:  2016-09-01       Impact factor: 60.622

2.  Evolution of coordinated mutagenesis and somatic hypermutation in VH5.

Authors:  Barbara E Wright; Karen H Schmidt; Aaron T Hunt; Dennis K Reschke; Michael F Minnick
Journal:  Mol Immunol       Date:  2011-11-05       Impact factor: 4.407

3.  Stabilised DNA secondary structures with increasing transcription localise hypermutable bases for somatic hypermutation in IGHV3-23.

Authors:  Bhargavi Duvvuri; Venkata R Duvvuri; Jianhong Wu; Gillian E Wu
Journal:  Immunogenetics       Date:  2012-03-06       Impact factor: 2.846

4.  V-region mutation in vitro, in vivo, and in silico reveal the importance of the enzymatic properties of AID and the sequence environment.

Authors:  Thomas MacCarthy; Susan L Kalis; Sergio Roa; Phuong Pham; Myron F Goodman; Matthew D Scharff; Aviv Bergman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-14       Impact factor: 11.205

5.  Transcription-associated mutagenesis increases protein sequence diversity more effectively than does random mutagenesis in Escherichia coli.

Authors:  Hyunchul Kim; Baek-Seok Lee; Masaru Tomita; Akio Kanai
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

6.  Gene Conversion-Like Events in the Diversification of Human Rearranged IGHV3-23*01 Gene Sequences.

Authors:  Bhargavi Duvvuri; Gillian E Wu
Journal:  Front Immunol       Date:  2012-06-15       Impact factor: 7.561

Review 7.  Transcription-associated mutagenesis.

Authors:  Sue Jinks-Robertson; Ashok S Bhagwat
Journal:  Annu Rev Genet       Date:  2014-09-10       Impact factor: 13.826

8.  Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID.

Authors:  Meng Wang; Cristina Rada; Michael S Neuberger
Journal:  J Exp Med       Date:  2010-01-04       Impact factor: 14.307

9.  Non-B DNA-Forming Motifs Promote Mfd-Dependent Stationary-Phase Mutagenesis in Bacillus subtilis.

Authors:  Tatiana Ermi; Carmen Vallin; Ana Gabriela Regalado García; Moises Bravo; Ismaray Fernandez Cordero; Holly Anne Martin; Mario Pedraza-Reyes; Eduardo Robleto
Journal:  Microorganisms       Date:  2021-06-12

10.  Spt5 accumulation at variable genes distinguishes somatic hypermutation in germinal center B cells from ex vivo-activated cells.

Authors:  Robert W Maul; Zheng Cao; Lakshmi Venkataraman; Carol A Giorgetti; Joan L Press; Yves Denizot; Hansen Du; Ranjan Sen; Patricia J Gearhart
Journal:  J Exp Med       Date:  2014-10-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.